Lv2
150 积分 2022-12-02 加入
Patterns of skin diseases among outpatients attending Hospital of Dermatology of Chinese Academy of Medical Sciences and Peking Union Medical College in 2019
4天前
已完结
Stapokibart: First Approval
1个月前
已完结
Long-Term Efficacy and Safety of Stapokibart in Adults with Moderate-to-Severe Atopic Dermatitis: An Open-Label Extension, Nonrandomized Clinical Trial
1个月前
已完结
Long‐term efficacy and safety of stapokibart for moderate‐to‐severe atopic dermatitis: 52‐week results from a phase 3 trial
1个月前
已完结
Efficacy and safety of stapokibart (CM310) in adults with moderate-to-severe atopic dermatitis: A multicenter, randomized, double-blind, placebo-controlled phase 3 trial
1个月前
已完结
Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline
1个月前
已完结
The Global Prevalence of Seborrheic Dermatitis
2个月前
已完结
The global, regional, and national burden of seborrheic dermatitis: results and insights from the Global Burden of Disease 2019 Study
2个月前
已完结
Efficacy and safety of topical minocycline foam (FMX101 4%) in treatment of Chinese subjects with moderate‐to‐severe facial acne vulgaris: A phase 3, multi‐centre, randomized, double‐blind, vehicle‐controlled study
2个月前
已完结
Chronic Prurigo
2个月前
已完结
皖公网安备34019202002308
